Jundishapur Journal of Microbiology

Published by: Kowsar

Cloning and Expression of Mycobacterium tuberculosis Major Secreted Protein Antigen 85B (Ag85B) in Escherichia coli

Reza Zarif 1 , * , Mojtaba Sankian 2 , Aida Gholubi 1 , Zahra Farshadzadeh 1 , Saman Soleimanpour 1 , Forough Youssefi 1 , Mehrangiz Khaje Karamoddini 1 , Kiarash Ghazvini 1 and Abdol Reza Varasteh 2
Authors Information
1 Microbiology & Virology Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Division of Immunobiochemistry, Immunology Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Jundishapur Journal of Microbiology: March 01, 2013, 6 (2); 112-116
  • Published Online: March 2, 2013
  • Article Type: Research Article
  • Received: March 4, 2012
  • Revised: May 22, 2012
  • Accepted: June 7, 2012
  • DOI: 10.5812/jjm.4701

To Cite: Zarif R, Sankian M, Gholubi A, Farshadzadeh Z, Soleimanpour S, et al. Cloning and Expression of Mycobacterium tuberculosis Major Secreted Protein Antigen 85B (Ag85B) in Escherichia coli, Jundishapur J Microbiol. 2013 ; 6(2):112-116. doi: 10.5812/jjm.4701.

Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999; 282(7): 677-86[DOI][PubMed]
  • 2. Grosset J. Current problems with tuberculosis treatment. Res Microbiol. 1996; 147(1-2): 10-6[DOI]
  • 3. Ratliff TL, McGarr JA, Abou-Zeid C, Rook GA, Stanford JL, Aslanzadeh J, et al. Attachment of mycobacteria to fibronectin-coated surfaces. J Gen Microbiol. 1988; 134(5): 1307-13[PubMed]
  • 4. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan , Besra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science. 1997; 276(5317): 1420-2[DOI][PubMed]
  • 5. Harth G, Lee BY, Wang J, Clemens DL, Horwitz MA. Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect Immun. 1996; 64(8): 3038-47[PubMed]
  • 6. Horwitz MA, Lee BW, Dillon BJ, Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA. 1995; 92(5): 1530-4[DOI][PubMed]
  • 7. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA. 2000; 97(25): 13853-8[DOI][PubMed]
  • 8. Kamath AT, Feng CG, Macdonald M, Briscoe H, Britton WJ. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun. 1999; 67(4): 1702-7[PubMed]
  • 9. Yanagisawa S, Koike M, Kariyone A, Nagai S, Takatsu K. Mapping of Vβ11+ helper T-cell epitopes on mycobacterial antigen in mouse primed with Mycobacterium tuberculosis. Int Immunol. 1997; 9: 227-37[DOI][PubMed]
  • 10. Chen A. Invitrogen™ life technologies, DNA pet101d_topo_verA, Restriction Map. 2002;
  • 11. Chang CC, Su YC, Cheng MS, Kan LS. Protein folding by a quasi-static-like process: a first-order state transition. Phys Rev E Stat Nonlin Soft Matter Phys. 2002; 66(2 Pt 1): 21903[DOI][PubMed]
  • 12. Matsuo K, Yamaguchi R, Yamazaki A, TasakaH , Yamada T. Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen. J Bacteriol. 1988; 170(9): 3847-54[PubMed]
  • 13. Russo DM, Kozlova N, Lakey DL, Kernodle D. Naive human T cells develop into Th1 effectors after stimulation with Mycobacterium tuberculosis-infected macrophages or recombinant Ag85 proteins. Infect Immun. 2000; 68(12): 6826-32[DOI][PubMed]
  • 14. Grover A, Ahmed MF, Singh B, Verma I, Sharma P, Khuller GK. A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens. Microbes Infect. 2006; 8(9-10): 2390-9[DOI][PubMed]
  • 15. Weinrich Olsen A, van Pinxteren LA, Meng Okkels L, Birk Rasmussen P, Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun. 2001; 69(5): 2773-8[DOI][PubMed]
  • 16. Al-Attiyah R, Mustafa AS, Abal AT, El-Shamy AS, Dalemans W, Skeiky YA. In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis. Clin Exp Immunol. 2004; 138(1): 139-44[DOI][PubMed]
  • 17. Lakey DL, Voladri RK, Edwards KM, Hager C, Samten B, Wallis RS, et al. Enhanced production of recombinant Mycobacterium tuberculosis antigens in Escherichia coli by replacement of low-usage codons. Infect Immun. 2000; 68(1): 233-8[DOI][PubMed]
  • 18. Kremer L, Maughan WN, Wilson RA, Dover LG, Besra GS. The M. tuberculosis antigen 85 complex and mycolyltransferase activity. Lett Appl Microbiol. 2002; 34(4): 233-7[DOI][PubMed]
  • 19. Yoneda M, Fukui Y, Yamanouchi T. Extracellular proteins of tubercle bacilli. V. Distribution of alpha and beta antigens in various mycobacteria. Biken J. 1965; 8(4): 201-23[PubMed]
  • 20. Invitrogen TM. coli Catalog nos. 2006;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments